Guardant Health Quarterly Income Statements Chart
Quarterly
|
Annual
Guardant Health Quarterly Income Statements Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| total revenue | 232,088,000 | 203,471,000 | 201,814,000 | 191,476,000 | 177,235,000 | 168,491,000 | 155,054,000 | 143,030,000 | 137,150,000 | 128,714,000 | 126,891,000 | 117,404,000 | 109,144,000 | 96,099,000 | 108,108,000 | 94,779,000 | 92,101,000 | 78,665,000 | 78,316,000 | 74,569,000 | 66,335,000 | 67,510,000 | 62,897,000 | 60,848,000 | 53,975,000 | 36,655,000 | 32,873,000 | 21,692,000 |
| yoy | 30.95% | 20.76% | 30.16% | 33.87% | 29.23% | 30.90% | 22.19% | 21.83% | 25.66% | 33.94% | 17.37% | 23.87% | 18.50% | 22.16% | 38.04% | 27.10% | 38.84% | 16.52% | 24.51% | 22.55% | 22.90% | 84.18% | 91.33% | 180.51% | ||||
| qoq | 14.06% | 0.82% | 5.40% | 8.04% | 5.19% | 8.67% | 8.41% | 4.29% | 6.55% | 1.44% | 8.08% | 7.57% | 13.57% | -11.11% | 14.06% | 2.91% | 17.08% | 0.45% | 5.02% | 12.41% | -1.74% | 7.33% | 3.37% | 12.73% | 47.25% | 11.50% | 51.54% | |
| costs and operating expenses: | ||||||||||||||||||||||||||||
| cost of revenue | 81,205,000 | 74,723,000 | ||||||||||||||||||||||||||
| gross profit | 150,883,000 | 128,748,000 | ||||||||||||||||||||||||||
| yoy | ||||||||||||||||||||||||||||
| qoq | 17.19% | |||||||||||||||||||||||||||
| gross margin % | 65.01% | 63.28% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| research and development expense | 87,449,000 | 88,521,000 | 93,543,000 | 87,306,000 | 83,102,000 | 83,802,000 | 89,856,000 | 93,851,000 | 90,359,000 | 93,128,000 | 106,578,000 | 100,017,000 | 85,455,000 | 81,757,000 | 73,021,000 | 70,968,000 | 63,724,000 | 55,508,000 | 40,282,000 | 36,245,000 | 36,319,000 | 37,016,000 | 25,875,000 | 24,569,000 | 19,532,000 | 16,316,000 | 16,652,000 | 14,253,000 |
| sales and marketing expense | 119,588,000 | 104,316,000 | 104,763,000 | 97,880,000 | 81,867,000 | 80,425,000 | 79,127,000 | 68,934,000 | 71,043,000 | 76,123,000 | 81,423,000 | 80,370,000 | 73,603,000 | 64,432,000 | 59,599,000 | 50,228,000 | 47,716,000 | 34,338,000 | 31,288,000 | 25,095,000 | 25,015,000 | 25,115,000 | 22,287,000 | 18,802,000 | 19,439,000 | 17,807,000 | 17,114,000 | 13,464,000 |
| general and administrative expense | 50,259,000 | 46,952,000 | 51,880,000 | 49,129,000 | 40,463,000 | 38,651,000 | 37,665,000 | 36,174,000 | 41,516,000 | 40,445,000 | 37,888,000 | 41,121,000 | 43,680,000 | 41,267,000 | 40,274,000 | 50,055,000 | 48,376,000 | 67,935,000 | 69,505,000 | 66,294,000 | 37,186,000 | 19,785,000 | 18,859,000 | 16,440,000 | 13,439,000 | 12,661,000 | 12,547,000 | 8,129,000 |
| total costs and operating expenses | 338,501,000 | 314,512,000 | 327,779,000 | 308,804,000 | 277,853,000 | 268,174,000 | 352,565,000 | 256,573,000 | 256,766,000 | 262,769,000 | 273,010,000 | 262,004,000 | 239,465,000 | 219,437,000 | 206,316,000 | 202,067,000 | 189,743,000 | 186,528,000 | 169,482,000 | 148,821,000 | 120,955,000 | 102,422,000 | 88,859,000 | 78,325,000 | 69,243,000 | 60,319,000 | 60,260,000 | 45,897,000 |
| income from operations | -106,413,000 | -111,041,000 | -125,965,000 | -117,328,000 | -100,618,000 | -99,683,000 | -197,511,000 | -113,543,000 | -119,616,000 | -134,055,000 | -146,119,000 | -144,600,000 | -130,321,000 | -123,338,000 | -98,208,000 | -107,288,000 | -97,642,000 | -107,863,000 | -91,166,000 | -74,252,000 | -54,620,000 | -34,912,000 | -25,962,000 | -17,477,000 | -15,268,000 | -23,664,000 | -27,387,000 | -24,205,000 |
| yoy | 5.76% | 11.39% | -36.22% | 3.33% | -15.88% | -25.64% | 35.17% | -21.48% | -8.21% | 8.69% | 48.79% | 34.78% | 33.47% | 14.35% | 7.72% | 44.49% | 78.77% | 208.96% | 251.15% | 324.86% | 257.74% | 47.53% | -5.20% | -27.80% | ||||
| qoq | -4.17% | -11.85% | 7.36% | 16.61% | 0.94% | -49.53% | 73.95% | -5.08% | -10.77% | -8.26% | 1.05% | 10.96% | 5.66% | 25.59% | -8.46% | 9.88% | -9.48% | 18.31% | 22.78% | 35.94% | 56.45% | 34.47% | 48.55% | 14.47% | -35.48% | -13.59% | 13.15% | |
| operating margin % | -45.85% | -54.57% | -62.42% | -61.28% | -56.77% | -59.16% | -127.38% | -79.38% | -87.22% | -104.15% | -115.15% | -123.16% | -119.40% | -128.34% | -90.84% | -113.20% | -106.02% | -137.12% | -116.41% | -99.57% | -82.34% | -51.71% | -41.28% | -28.72% | -28.29% | -64.56% | -83.31% | -111.58% |
| interest income | 7,560,000 | 9,112,000 | 11,653,000 | 13,257,000 | 13,913,000 | 14,868,000 | 13,888,000 | 11,690,000 | 6,727,000 | 3,060,000 | 2,150,000 | 1,754,000 | 1,387,000 | 778,000 | 653,000 | 689,000 | 1,037,000 | 1,551,000 | 1,900,000 | 2,313,000 | 2,640,000 | 3,318,000 | 3,871,000 | 4,286,000 | 3,099,000 | 2,485,000 | 2,334,000 | 958,000 |
| interest expense | -983,000 | -791,000 | -645,000 | -646,000 | -645,000 | -645,000 | -645,000 | -644,000 | -645,000 | -644,000 | -644,000 | -644,000 | -645,000 | -644,000 | -643,000 | -644,000 | -644,000 | -646,000 | -4,736,000 | -8,000 | -10,000 | -12,000 | -321,000 | -280,000 | -287,000 | -293,000 | -299,000 | -304,000 |
| other income | -25,000 | 7,851,000 | 4,667,000 | -3,007,000 | -15,145,000 | -29,120,000 | -3,316,000 | 16,885,000 | 41,259,000 | -1,654,000 | 5,281,000 | -18,389,000 | 378,000 | -48,000 | 25,898,000 | -187,000 | -243,000 | -290,000 | 1,220,000 | 345,000 | 2,285,000 | -209,000 | -187,000 | 179,000 | -51,000 | 147,000 | 115,000 | 43,000 |
| income before benefit from income taxes | -99,861,000 | -94,869,000 | -110,290,000 | -107,724,000 | -102,495,000 | -114,580,000 | -187,584,000 | -85,612,000 | -72,275,000 | -133,293,000 | -139,332,000 | -161,879,000 | -228,986,000 | -123,252,000 | -72,300,000 | -107,430,000 | -97,492,000 | -107,248,000 | -92,782,000 | -71,602,000 | -49,705,000 | -31,815,000 | -22,599,000 | -13,292,000 | -12,507,000 | -21,325,000 | -25,237,000 | -23,508,000 |
| benefit from income taxes | 38,000 | 290,000 | 716,000 | 30,000 | 133,000 | 405,000 | -541,000 | 490,000 | 496,000 | 240,000 | 602,000 | 115,000 | 446,000 | -24,000 | 11,000 | 96,000 | 83,000 | 110,000 | 263,000 | 68,000 | 34,000 | 14,000 | -489,000 | -202,000 | -1,207,000 | 26,000 | 35,000 | |
| net income | -99,899,000 | -95,159,000 | -111,006,000 | -107,754,000 | -102,628,000 | -114,985,000 | -187,043,000 | -86,102,000 | -72,771,000 | -133,533,000 | -139,934,000 | -161,994,000 | -229,432,000 | -123,228,000 | -72,311,000 | -107,526,000 | -97,575,000 | -107,358,000 | -93,045,000 | -71,670,000 | -49,739,000 | -31,829,000 | -22,110,000 | -13,090,000 | -11,300,000 | -21,351,000 | -25,272,000 | -23,508,000 |
| yoy | -2.66% | -17.24% | -40.65% | 25.15% | 41.03% | -13.89% | 33.67% | -46.85% | -68.28% | 8.36% | 93.52% | 50.66% | 135.13% | 14.78% | -22.28% | 50.03% | 96.17% | 237.30% | 320.83% | 447.52% | 340.17% | 49.07% | -12.51% | -44.32% | ||||
| qoq | 4.98% | -14.28% | 3.02% | 4.99% | -10.75% | -38.52% | 117.23% | 18.32% | -45.50% | -4.57% | -13.62% | -29.39% | 86.18% | 70.41% | -32.75% | 10.20% | -9.11% | 15.38% | 29.82% | 44.09% | 56.27% | 43.96% | 68.91% | 15.84% | -47.08% | -15.52% | 7.50% | |
| net income margin % | -43.04% | -46.77% | -55.00% | -56.28% | -57.91% | -68.24% | -120.63% | -60.20% | -53.06% | -103.74% | -110.28% | -137.98% | -210.21% | -128.23% | -66.89% | -113.45% | -105.94% | -136.47% | -118.81% | -96.11% | -74.98% | -47.15% | -35.15% | -21.51% | -20.94% | -58.25% | -76.88% | -108.37% |
| net income per share | -0.8 | -0.77 | -0.9 | -0.88 | -0.84 | -0.94 | -1.62 | -0.73 | -0.67 | -1.3 | -1.37 | -1.58 | -2.25 | -1.21 | -0.89 | -1.06 | -0.96 | -1.09 | -0.94 | -0.78 | -0.57 | -0.29 | -0.28 | -0.14 | -0.13 | -0.3 | 2.07 | -1.94 |
| weighted-average shares used for eps calculation | 124,114 | 123,871 | 122,745 | 123,051 | 122,447 | 121,712 | 111,988 | 117,736 | 108,808 | 102,663 | 102,178 | 102,289 | 102,047 | 101,853 | 101,314 | 101,420 | 101,172 | 100,955 | 97,504 | 99,554 | 96,011 | 94,382 | 90,597 | 93,303 | 89,036 | 85,935 | 30,403 | 12,582 |
| revenue: | ||||||||||||||||||||||||||||
| precision oncology testing | 184,585,000 | 180,604,000 | 166,518,000 | 156,229,000 | 142,189,000 | 133,423,000 | 125,244,000 | 113,393,000 | 113,797,000 | 102,054,000 | 92,062,000 | 84,136,000 | 88,707,000 | 79,272,000 | 72,604,000 | 63,729,000 | 64,703,000 | 60,384,000 | 50,991,000 | 60,246,000 | 57,414,000 | 52,147,000 | 42,064,000 | 28,837,000 | 28,096,000 | 18,298,000 | ||
| development services and other | 17,229,000 | 10,872,000 | 10,717,000 | 12,262,000 | 12,865,000 | 9,607,000 | 11,906,000 | 15,321,000 | 13,094,000 | 15,350,000 | 17,082,000 | 11,963,000 | 19,401,000 | 15,507,000 | 19,497,000 | 14,936,000 | 13,613,000 | 14,185,000 | ||||||||||
| cost of precision oncology testing | 69,465,000 | 66,095,000 | 65,715,000 | 59,306,000 | 57,417,000 | 53,648,000 | 49,357,000 | 45,106,000 | 43,706,000 | 39,434,000 | 34,375,000 | 30,684,000 | 32,254,000 | 29,665,000 | 24,887,000 | 23,590,000 | 22,070,000 | 16,699,000 | 17,809,000 | 18,191,000 | 20,004,000 | 16,578,000 | 14,650,000 | 11,023,000 | 12,624,000 | 9,671,000 | ||
| cost of development services and other | 8,128,000 | 8,394,000 | 6,706,000 | 5,990,000 | 5,100,000 | 3,966,000 | 4,491,000 | 7,967,000 | 3,415,000 | 1,062,000 | 2,352,000 | 1,297,000 | 1,168,000 | 1,151,000 | 5,040,000 | 5,157,000 | 6,337,000 | 4,488,000 | ||||||||||
| fair value adjustments of noncontrolling interest liability | -99,785,000 | |||||||||||||||||||||||||||
| adjustment of redeemable noncontrolling interest | -18,600,000 | -2,300,000 | -700,000 | -6,000,000 | -4,900,000 | 4,100,000 | ||||||||||||||||||||||
| net income attributable to guardant health, inc. common stockholders | -139,934,000 | -161,994,000 | -229,432,000 | -123,228,000 | -90,911,000 | -107,526,000 | -97,575,000 | -109,658,000 | -93,745,000 | -77,670,000 | -54,639,000 | -27,729,000 | -25,210,000 | -12,790,000 | -11,600,000 | -26,051,000 | -25,122,000 | -24,458,000 | ||||||||||
| development services | 15,344,000 | 7,264,000 | 5,483,000 | 8,701,000 | 11,911,000 | 7,818,000 | 4,777,000 | 3,394,000 | ||||||||||||||||||||
| cost of development services | 4,626,000 | 2,315,000 | 1,834,000 | 1,936,000 | 2,183,000 | 2,512,000 | 1,323,000 | 380,000 | ||||||||||||||||||||
| fair value adjustment of redeemable noncontrolling interest | -1,175,000 | 300,000 | -300,000 | -4,700,000 | 150,000 | -950,000 | ||||||||||||||||||||||
| loss on debt extinguishment | ||||||||||||||||||||||||||||
| net income attributable to guardant health, inc. | -25,122,000 | -24,458,000 | ||||||||||||||||||||||||||
| deemed dividend related to repurchase of series a convertible preferred stock | ||||||||||||||||||||||||||||
| deemed dividend related to change in conversion rate of series d convertible preferred stock |
We provide you with 20 years income statements for Guardant Health stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Guardant Health stock. Explore the full financial landscape of Guardant Health stock with our expertly curated income statements.
The information provided in this report about Guardant Health stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.